Literature DB >> 7626566

DNA index and S phase fraction in uveal malignant melanomas.

W G Hodge1, A J Duclos, G Rocha, E Antecka, M G Baines, C Corriveau, S Brownstein, J Deschenes.   

Abstract

AIMS: To predict 5 year survival in patients with uveal malignant melanomas DNA indices were studied.
METHODS: Using 45 paraffin embedded uveal malignant melanomas, the DNA index and S phase fraction of each tumour were the predictor variables recorded.
RESULTS: Using the Cox proportional hazards model, aneuploid tumours and tumours which had an S phase fraction greater than 4% were significant predictors of early death. In order to demonstrate a biological gradient between a larger DNA index and shorter survival time, linear regression and transformed linear regression models were used. However, no such gradient could be demonstrated.
CONCLUSION: Although this study shows promise for the use of DNA studies in the prognosis of uveal malignant melanoma, the exact role of these techniques remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626566      PMCID: PMC505158          DOI: 10.1136/bjo.79.6.521

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  35 in total

Review 1.  Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms.

Authors:  R P Wersto; R L Liblit; L G Koss
Journal:  Hum Pathol       Date:  1991-11       Impact factor: 3.466

Review 2.  Chromosomes in leukemia and lymphoma.

Authors:  J D Rowley
Journal:  Semin Hematol       Date:  1978-07       Impact factor: 3.851

3.  Cellular DNA content as a marker of neoplasia in man.

Authors:  B Barlogie; B Drewinko; J Schumann; W Göhde; G Dosik; J Latreille; D A Johnston; E J Freireich
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

Review 4.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

5.  The influence of tumour cell DNA abnormalities on survival in colorectal cancer.

Authors:  N C Armitage; R A Robins; D F Evans; D R Turner; R W Baldwin; J D Hardcastle
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

6.  DNA distribution in human colon carcinomas and its relationship to clinical behavior.

Authors:  R C Wolley; K Schreiber; L G Koss; M Karas; A Sherman
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

7.  Malignant melanoma: analysis by DNA flow cytometry.

Authors:  J Wass; R A Zbroja; G A Young; P C Vincent; R M Joyce; G Croaker
Journal:  Pathology       Date:  1985-07       Impact factor: 5.306

8.  The proliferative index (PI) of human breast cancer as obtained by flow cytometry.

Authors:  D Haag; K Goerttler; C Tschahargane
Journal:  Pathol Res Pract       Date:  1984-03       Impact factor: 3.250

9.  Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.

Authors:  P B Coulson; J T Thornthwaite; T W Woolley; E V Sugarbaker; D Seckinger
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

10.  DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.

Authors:  M Karlsson; B Boeryd; J Carstensen; B Kågedal; A T Bratel; S Wingren
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more
  1 in total

1.  Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.

Authors:  T Kodama; K Kawamoto; T Kono; Y Shibuya; T Setogawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.